CIBC Private Wealth Group
CTSO icon

CIBC Private Wealth Group’s Cytosorbents Corp CTSO Stock Holding History

CIBC Private Wealth Group’s Portfolio CTSO Stock Details CTSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$110K Hold
172,649
– – ﹤0.01% 1462
2025
Q3 		$161K Hold
172,649
– – ﹤0.01% 1272
2025
Q2 		$221K Hold
172,649
– – ﹤0.01% 1089
2025
Q1 		$166K Hold
172,649
– – ﹤0.01% 1148
2024
Q4 		$167K Hold
172,649
– – ﹤0.01% 1224
2024
Q3 		$259K Hold
172,649
– – ﹤0.01% 1078
2024
Q2 		$174K Hold
172,649
– – ﹤0.01% 1162
2024
Q1 		$157K Hold
172,649
– – ﹤0.01% 1218
2023
Q4 		$192K Buy
172,649
+50,000
+41% +$74.3K ﹤0.01% 1078
2023
Q3 		$231K Buy
+122,649
New +$352K ﹤0.01% 962

Other funds holding CTSO

AC
Avenir Corporation Alexandria, Virginia $821M AUM 4.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SC
Skylands Capital Milwaukee, Wisconsin $814M AUM 32.37% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $832M AUM 24.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Pathstone Holdings
Pathstone Holdings Englewood, New Jersey $34.3B AUM 27.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

CIBC Private Wealth Group's CTSO Position: Q4 2025 in Review

CIBC Private Wealth Group held its Cytosorbents Corp (CTSO) position steady in Q4 2025 at 172,649 shares worth $110K. The position accounts for ﹤0.01% of the portfolio, ranked #1462.

CIBC Private Wealth Group first reported a position in CTSO in Q3 2023 and has held it in 10 quarters since. The position peaked at $259K in Q3 2024. 51 funds tracked by Wall St. Rank hold CTSO as of Q4 2025.

  • CIBC Private Wealth Group held 172,649 shares of Cytosorbents Corp worth $110K as of Q4 2025.
  • CIBC Private Wealth Group left its Cytosorbents Corp share count unchanged in Q4 2025.
  • Cytosorbents Corp made up ﹤0.01% of CIBC Private Wealth Group's portfolio in Q4 2025, its #1462 holding.
  • CIBC Private Wealth Group first reported a position in Cytosorbents Corp in Q3 2023 and has held it in 10 quarters since.
  • CIBC Private Wealth Group's Cytosorbents Corp position peaked at $259K in Q3 2024.
  • 51 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q4 2025.

Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.